Table of Contents Author Guidelines Submit a Manuscript
Cardiology Research and Practice
Volume 2016, Article ID 3708210, 9 pages
http://dx.doi.org/10.1155/2016/3708210
Research Article

Role of Neutrophil Gelatinase-Associated Lipocalin in the Diagnosis and Early Treatment of Acute Kidney Injury in a Case Series of Patients with Acute Decompensated Heart Failure: A Case Series

1Clinical Pathology and Microbiology Laboratory, University Hospital Campus Bio-Medico, Via Alvaro del Portillo 200, 00128 Rome, Italy
2Centro Integrato di Ricerche (CIR), Laboratory of Clinical Pathology and Microbiology, University “Campus Bio-Medico”, Via Alvaro del Portillo 200, 00128 Rome, Italy
3Internal Medicine Department, University Hospital Campus Bio-Medico, Via Alvaro del Portillo 200, 00128 Rome, Italy
4Department of Infectious, Parasitic and Immunomediated Diseases, National Institute of Health, Viale Regina Elena 299, 00161 Rome, Italy

Received 1 December 2015; Accepted 1 February 2016

Academic Editor: Stephan von Haehling

Copyright © 2016 Silvia Angeletti et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. T. Murray, R. L. Mehta, A. Shaw et al., “Potential use of biomarkers in acute kidney injury: report and summary of recommendations from the 10th Acute Dialysis Quality Initiative consensus conference,” Kidney International, vol. 85, no. 3, pp. 513–521, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. S. G. Coca, B. Yusuf, M. G. Shlipak, A. X. Garg, and C. R. Parikh, “Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis,” American Journal of Kidney Diseases, vol. 53, no. 6, pp. 961–973, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. P. A. McCullough, “Cardiorenal syndromes: pathophysiology to prevention,” International Journal of Nephrology, vol. 2011, Article ID 762590, 10 pages, 2011. View at Publisher · View at Google Scholar
  4. K. Damman, G. Navis, A. A. Voors et al., “Worsening renal function and prognosis in heart failure: systematic review and meta-analysis,” Journal of Cardiac Failure, vol. 13, no. 8, pp. 599–608, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Joslin and M. Ostermann, “Care of the critically ill emergency department patient with acute kidney injury,” Emergency Medicine International, vol. 2012, Article ID 760623, 6 pages, 2012. View at Publisher · View at Google Scholar
  6. A. Haase-Fielitz, M. Haase, and P. Devarajan, “Neutrophil gelatinase-associated lipocalin as a biomarker of acute kidney injury: a critical evaluation of current status,” Annals of Clinical Biochemistry, vol. 51, no. 3, pp. 335–351, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. E. A. J. Hoste, G. Clermont, A. Kersten et al., “RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis,” Critical Care, vol. 10, no. 3, article R73, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Chuasuwan and J. A. Kellum, “Acute kidney injury and its management,” Contributions to Nephrology, vol. 171, pp. 218–225, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. S. M. Bagshaw, C. George, and R. Bellomo, “A comparison of the RIFLE and AKIN criteria for acute kidney injury in critically ill patients,” Nephrology Dialysis Transplantation, vol. 23, no. 5, pp. 1569–1574, 2008. View at Publisher · View at Google Scholar
  10. J. A. Lopes and S. Jorge, “The RIFLE and AKIN classifications for acute kidney injury—a critical and comprehensive review,” Clinical Kidney Journal, vol. 6, no. 1, pp. 8–14, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. “Kidney Disease Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group: KDIGO clinical practice guideline for acute kidney injury,” Kidney International Supplements, vol. 2, no. 1, pp. 1–138, 2012. View at Publisher · View at Google Scholar
  12. S. Uchino, R. Bellomo, D. Goldsmith, S. Bates, and C. Ronco, “An assessment of the RIFLE criteria for acute renal failure in hospitalized patients,” Critical Care Medicine, vol. 34, no. 7, pp. 1913–1917, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. R. L. Mehta, J. A. Kellum, S. V. Shah et al., “Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury,” Critical Care, vol. 11, no. 2, article R31, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Haase, P. Devarajan, A. Haase-Fielitz et al., “The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies,” Journal of the American College of Cardiology, vol. 57, no. 17, pp. 1752–1761, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Haase, R. Bellomo, P. Devarajan et al., “Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis,” American Journal of Kidney Diseases, vol. 54, no. 6, pp. 1012–1024, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. T. L. Nickolas, K. M. Schmidt-Ott, P. Canetta et al., “Diagnostic and prognostic stratification in the emergency department using urinary biomarkers of nephron damage: a multicenter prospective cohort study,” Journal of the American College of Cardiology, vol. 59, no. 3, pp. 246–255, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Urbschat, N. Obermüller, and A. Haferkamp, “Biomarkers of kidney injury,” Biomarkers, vol. 16, supplement 1, pp. S22–S30, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Mishra, Q. Ma, A. Prada et al., “Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury,” Journal of the American Society of Nephrology, vol. 14, no. 10, pp. 2534–2543, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Alvelos, P. Lourenço, C. Dias et al., “Prognostic value of neutrophil gelatinase-associated lipocalin in acute heart failure,” International Journal of Cardiology, vol. 165, no. 1, pp. 51–55, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. A. S. Maisel, C. Mueller, R. Fitzgerald et al., “Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: the NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial,” European Journal of Heart Failure, vol. 13, no. 8, pp. 846–851, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. B. De Berardinis, H. K. Gaggin, L. Magrini et al., “Comparison between admission natriuretic peptides, NGAL and sST2 testing for the prediction of worsening renal function in patients with acutely decompensated heart failure,” Clinical Chemistry and Laboratory Medicine, vol. 53, no. 4, pp. 613–621, 2015. View at Google Scholar
  22. M. Legr, B. De Berardinis, H. K. Gaggin et al., “Evidence of uncoupling between renal dysfunction and injury in cardiorenal syndrome: insights from the BIONICS study,” PLoS ONE, vol. 9, no. 11, Article ID e112313, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Park, E. Vittinghoff, K. D. Liu, M. G. Shlipak, and C.-Y. Hsu, “Urine biomarkers neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule-1 (KIM-1) have different patterns in hheart failure eexacerbation,” Biomarker Insights, vol. 8, pp. 15–18, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. D. R. McIlroy, G. Wagener, and H. T. Lee, “Neutrophil gelatinase-associated lipocalin and acute kidney injury after cardiac surgery: the effect of baseline renal function on diagnostic performance,” Clinical Journal of the American Society of Nephrology, vol. 5, no. 2, pp. 211–219, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Donadio, “Effect of glomerular filtration rate impairment on diagnostic performance of neutrophil gelatinase-associated lipocalin and B-type natriuretic peptide as markers of acute cardiac and renal failure in chronic kidney disease patients,” Critical Care, vol. 18, no. 1, article R39, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Di Somma, L. Magrini, B. De Berardinis et al., “Additive value of blood neutrophil gelatinase-associated lipocalin to clinical judgement in acute kidney injury diagnosis and mortality prediction in patients hospitalized from the emergency department,” Critical Care, vol. 17, no. 1, article R29, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. C. W. Yancy, M. Jessup, B. Bozkurt et al., “2013 ACCF/AHA guideline for the management of heart failure: a report of the American college of cardiology foundation/american heart association task force on practice guidelines,” Journal of the American College of Cardiology, vol. 62, no. 16, pp. e147–e239, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. J. J. V. McMurray, S. Adamopoulos, S. D. Anker et al., “ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC,” European Heart Journal, vol. 33, no. 14, pp. 1787–1847, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. C. L. Dent, Q. Ma, S. Dastrala et al., “Plasma neutrophil gelatinase-associated lipocalin predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: a prospective uncontrolled cohort study,” Critical Care, vol. 11, no. 6, article R127, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. C. Ronco, D. Cruz, and B. W. Noland, “Neutrophil gelatinase-associated lipocalin curve and neutrophil gelatinase-associated lipocalin extended-range assay: a new biomarker approach in the early diagnosis of acute kidney injury and cardio-renal syndrome,” Seminars in Nephrology, vol. 32, no. 1, pp. 121–128, 2012. View at Publisher · View at Google Scholar · View at Scopus